Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabozantinib in Advanced Non-Clear Cell RCC (UNICAB)
NCT03685448Phase 2Completed
- Sponsor
- ANZUP Cancer Trials Group
- Start
- Apr 2019
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cabozantinib in non-clear cell renal cell carcinoma (nccRCC), sponsored by ANZUP Cancer Trials Group. Started Apr 2019; status: completed.
02
Drugs
cabozantinib
03
Conditions
non-clear cell renal cell carcinoma (nccRCC)
Beyond the preview
Go deeper on NCT03685448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03685448.